Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CFP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
DCT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HNMT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C5orf63 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD84 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928985 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CDC23 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZFP82 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NT5C1B-RDH14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF708 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SH3TC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GGT5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C16orf72 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARID4B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC648761 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHERP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TP53INP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on